Deals Of The Week: Allena/Althea, Almirall/Menarini, Bausch & Lomb/Ista
Executive Summary
Earn-outs are more frequent in biotech M&A deals these days, but private investors also are becoming more savvy in terms of tracking earn-outs and which ones are more likely than others to pay off.